TXONE-S 1.5 Injection combines Ceftriaxone, a broad-spectrum cephalosporin antibiotic, with Sulbactam, a beta-lactamase inhibitor. This synergistic formulation enhances effectiveness against resistant bacterial strains, ensuring reliable treatment outcomes for severe infections.
Key Benefits:
-
Broad-spectrum antibacterial coverage
-
Effective against resistant bacterial infections
-
Suitable for IM/IV administration
-
Enhances efficacy by combining antibiotic with beta-lactamase inhibitor
Reviews
There are no reviews yet.